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Binding of an Indenoisoquinoline to the TopoisomeraseDNA Complex Induces Reduction of Linker Mobility and
Strengthening of Protein-DNA Interaction
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Abstract
Long-duration comparative molecular dynamics simulations of the DNA-topoisomerase binary and DNA-topoisomeraseindenoisoquinoline ternary complexes have been carried out. The analyses demonstrated the role of the drug in
conformationally stabilizing the protein-DNA interaction. In detail, the protein lips, clamping the DNA substrate, interact
more tightly in the ternary complex than in the binary one. The drug also reduces the conformational space sampled by the
protein linker domain through an increased interaction with the helix bundle proximal to the active site. A similar alteration
of linker domain dynamics has been observed in a precedent work for topotecan but the molecular mechanisms were
different if compared to those described in this work. Finally, the indenoisoquinoline keeps Lys532 far from the DNA,
making it unable to participate in the religation reaction, indicating that both short- and long-range interactions contribute
to the drug poisoning effect.
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a nucleophilic attack on one strand of the dsDNA forming
a covalent protein-DNA complex at the 39 end, termed the
cleavage complex; 3) the broken strand rotates around the
unbroken strand, controlled by the interaction with the linker
domain, relaxing the supercoil; 4) the broken strand is religated; 5)
the protein is released [5].
hTopIB has a relevant clinical role, being highly active in cells
with a high level of duplication, i.e. cancer cells, and being the
unique target of the camptothecins (CPTs), a class of natural
compounds with anticancer activity [6–8]. CPT, the parental
compound of the class, acts by stabilizing the cleavage complex
and preventing the religation step. The binding of CPTs to the
cleavage complex is per se reversible, but the compound becomes
lethal due to the collision of the stalled enzyme-DNA complex with
the replication fork [9–11]. CPT and its derivatives, such as
topotecan (TPT), bind the binary complex intercalating between
the bases of the DNA substrate at the cleavage site. The ternary
complex is further stabilized by interactions of the drug with the
protein, as shown by the X-ray structure of the protein-DNA-drug
ternary complexes [12,13]. Molecular dynamics (MD) simulation
of the hTopIB-DNA-TPT ternary complex has highlighted the
elements important for the TPT stabilization and has revealed an
unusual rigidity of the linker domain when compared to the binary

Introduction
Human topoisomerase IB (hTopIB) is a nuclear enzyme whose
role is to control the topological state of DNA. It catalyzes the
relaxation of supercoiled substrates in order to permit fundamental
cellular processes, such as transcription and replication, [1,2]. The
enzyme is composed of 765 residues divided into an N-terminal
domain (residues 1–214), a core domain (residues 215–635) further
subdivided into subdomain I (residues 215–232 and 320–433),
subdomain II (residues 233–319) and subdomain III (residues 434–
635), a linker domain (residues 636–712) and a C-terminal domain
(residues 713–765) [3–5]. The protein has a globular shape, with
subdomains I and II forming the CAP domain and subdomain III
and C-terminal domain forming the CAT domain (Figure 1A) [4].
The linker domain is formed by two long a-helices that extrude
outside from the globular shape of the protein (Figure 1A).
hTopIB resolves DNA supercoils by a mechanism defined as
controlled rotation, which is composed by 5 steps: 1) the protein
wraps around the substrate forming a non-covalent hTopIB-DNA
complex, which is stabilized by intra- and inter-molecular
hydrogen bonds and electrostatic interactions; 2) the catalytic
Tyr723, assisted by the other four residues composing the catalytic
pentad (Arg488, Lys532, Arg590 and His632), carries out
PLOS ONE | www.plosone.org
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Figure 1. Structure of the ternary complex. (A) three-dimensional structure of the hTopIB-DNA-IQN2 ternary complex. Topoisomerase core
subdomains I, II and III are represented in blue, yellow and red, respectively, while the linker and C-terminal domains in green and cyan, respectively.
DNA strands are colored in orange (uncleaved strand), purple (cleaved upstream) and dark purple (cleaved downstream). IQN2 is shown in magenta
using ball and stick representation. Chemical structures of AI-III-52 (1), NSC 314622 (IQN2) (2) and MJ-238 (3).
doi:10.1371/journal.pone.0051354.g001

physiological pH. The indenoisoquinolines also display a more
persistent stabilization of the cleavage complex than CPTs and
that they do not represent a substrate for the ABCG2 efflux pump
[16–19].
The first IQN synthesized and tested against hTopIB was NSC
314622 [20], followed by the synthesis of several derivatives, two of
them, NSC 725776 and NSC 724998, being now in phase I

complex [14]. Recently new hTopIB inhibitors have been
developed and among them the indenoisoquinoline (IQN)
derivatives appear to be the most promising ones [14–16]. They
stabilize the cleavage complex through a similar intercalation
binding mechanism displayed by CPTs, but they seem more
promising for clinical use due to their chemical stability, while
CPT undergoes inactivation by lactone ring hydrolysis at
PLOS ONE | www.plosone.org
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tions have been taken into account by means of the Particle Mesh
Ewald method (PME) using a cutoff of 1.2 nm for the real space
and Van der Waals interactions [29,30]. The LINCS algorithm
was used to constrain bond lengths and angles [31]. Relaxation of
solvent molecules and Na+ ions was initially performed keeping
solute atoms restrained to their initial positions with a force
constant of 1000 kJ/(mol N nm), for 3500 ps. The two systems have
then been simulated for 75 ns with a time step of 2.0 fs and the
neighbor list was updated every 10 steps. Temperature was kept
constant at 300 K using the velocity rescale method with
a coupling constant of 0.1 ps during sampling, while pressure
was kept constant at 1 bar using the Parrinello-Rahman barostat
with a coupling constant of 1.0 ps during sampling [32,33].
Root mean square deviations (RMSD) were calculated using the
following formula (after a mass-weighted least square fitting to
a reference structure):

clinical trials [18]. Up to now the crystal structures of the ternary
complexes with IQN derivatives have been solved only in presence
of AI-III-52 and MJ-238 (structures 1 and 3 in Figure 1B)
[12,21,22]. In the case of the MJ-238 compound, the drug is
intercalated in the DNA substrate with the substituent on the
nitrogen atom facing the DNA major groove, due to the steric
hindrance of the substituent [12]. In the case of the compound AIIII-52 the orientation of the drug in the binding pocket is flipped
180u with respect to first one, with the nitrogen atom facing the
DNA minor groove [21,22].
No 3D structure is available for the ternary complex with NSC
314622, which represents the lead compound of IQNs already in
clinical trial (NSC 725776 and NSC 724998). NSC 314622
displays a moderate anti-topoisomerase activity [23] and differs
from AI-III-52 in the presence of two oxygen substituent in
position 5 and 11 and a methyl substituent in position 6 (structure
2 in Figure 1B). The evaluation of its mode of binding can provide
useful information on its mechanism of stabilization of the
cleavage complex. To this aim the compound NSC 314622,
termed IQN2, has been modeled taking the ternary complex in
presence of AI-III-52 as a template and 75 ns comparative
molecular dynamics simulations of the hTopIB-DNA binary and
hTopIB-DNA-IQN2 ternary complexes have been carried out.
The results show that the drug conformationally stabilizes the
protein-DNA complex reducing the fluctuation of the lips and
decreases the conformational space sampled by the linker domain
due to the increased compactness of the helix bundle proximal to
the active site.

rﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 X
mi kri ðt1 Þ{ri ðt0 Þk2
RMSDðt1, t0 Þ~
M
where M is the sum of atomic masses, mi is the mass of atom i and
t = 0 refers to the selected reference structure. The per-residue root
mean square fluctuations (RMSF) were computed using the
following equation:
rﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ

2
1 1 X
mi S rij ðtÞ{rij TMD
RMSFi ~
TM

Materials and Methods

where the averages have been calculated over the equilibrated MD
trajectories.
Principal components analysis (PCA) was carried out on the
3N63N cartesian displacement matrix whose elements are
calculated as:

The initial configuration of hTopIB, in covalent complex with
a 22 base pair linear double helix DNA substrate, has been
modeled from the crystallographic structures of the binary and
ternary complexes (PDB 1K4S and 1TL8, respectively) [13,22].
For the binary complex the starting positions for residues 201–631
and 708–765 have been obtained from the 1K4S crystal structure
and those for residues 632–707 from the 1TL8 crystal structure
(since the linker domain is not resolved in the former), following
a mass-weighted fit of backbone atoms on 1K4S that gives rise to
an RMSD between the two structures of 0.5 Å after the fit. As far
as the ternary complex is concerned, both the 1SC7 and 1TL8 3D
structures may be considered as a template (12,22), the latter one
being selected since the dimension of the AI-III-52, present in the
1TL8 structure, and the NSC 314622 (IQN2) compounds are very
similar and both lack a butyric substituent on the nitrogen atom in
position 6 (Figure 1). The same 22 base pair DNA sequence of the
ternary complex was used in both systems (nucleotides in relevant
positions in the binary system were mutated using the rotamer
module presents in the Chimera package [24]). The systems have
been modeled using the AMBER03 all-atom force field [25]
implemented by Sorin and Pande [26] in the GROMACS MD
package version 4.0.7 [27]. The protein has been immersed in
a rhombic dodecahedron box with a minimum distance of 14 Å
from the box edges. The box was then filled with water molecules
described by means of the TIP3P rigid potential [28] and Na+
counter-ions have been added to neutralize DNA-enzyme
complex total charge using the genion tool of the GROMACS
package, which randomly substitutes water molecules with ions at
the most favorable electrostatic potential positions. The resulting
systems are composed of 9456 protein atoms, 1400 DNA atoms,
58919 water molecules, 20 Na+ ions and one IQN2 molecule in
the ternary complex, for a total of 187633 and 187591 atoms in
the ternary and binary systems, respectively. Electrostatic interacPLOS ONE | www.plosone.org

cij ~Sqi qj T
where N is the number of Ca protein or C59 DNA atoms of the
two systems and qi is the (mass-weighted) displacement of the i-th
Ca protein or C59 DNA atoms from the reference value (after
removal of rotational and translational degrees of freedom). The
first few eigenvectors of the diagonalized covariance matrix usually
account for a major fraction of the total variance and projection of
atomic trajectories over the corresponding eigenvectors represents
large collective atomic motions. The cosine content (ci) of
a principal component pi is a good indicator for good simulation
sampling [33]. It ranges between 0 and 1 and is calculate in the
following way:

ci ~

2
T

ð

cosðiptÞpi ðtÞdt

2 ð

{1
p2i ðtÞdt

where t and T are instantaneous and total simulation time,
respectively. High values of ci (close to 1) are indicative of random
diffusion motion and therefore insufficient sampling. Cosine
contents along these eigenvectors have maximum values of 0.11
and 0.27 for the binary and ternary complex, respectively, (with
the exception of principal component 3 in the binary trajectory
that has a cosine content of 0.55; however this eigenvector
accounts only for about 3% of total variance) indicating
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a satisfactory convergence of simulations along these principal
components.
To compare the two simulations, sampled structures were
clustered considering only the backbone atoms using the
GROMOS method: after the construction of the M6M RMSD
matrix (where M is the number of sampled structures). The
structure with the largest number of neighbors (i.e. configurations
within the cutoff range) is taken as the centroid of the first cluster
and it is eliminated by the pool with all its neighbors; the process is
repeated until all structures have been assigned to a cluster. A total
of 7000 frames from each simulation were selected with constant
pace of 10 ps to ensure absence of correlation between neighbor
frames and then used in the cluster analysis.
All analyses have been carried out with standard tools present in
the GROMACS MD package v. 4.0.7 [27] or in-house written
codes, except for secondary structure assignment, which was
performed by means of the DSSP program [34]. Graphs have
been obtained with the Grace program (Grace. http://plasmagate.weizmann.ac.il/Grace/) and images have been created using
the VMD [35] and Chimera packages [24].

Results
Protein and Linker Mobility
RMSD calculated on the Ca atoms of hTopIB in the binary and
ternary complexes shows that in both cases the protein displays
a highly oscillating behaviour up to a value of 4 and 3 Å,
respectively (Supporting Figure S1, dashed lines). On the other
hand, once the contribution of the linker domain is excluded from
the calculation the RMSD reaches a plateau slightly larger in the
binary than in the ternary complex (Supporting Figure S1, full
lines). These data indicate that the linker is the most mobile
domain of the protein and demonstrates that the presence of the
drug has a remarkable stabilizing effect. Clustering of the protein
structures extracted from the simulations, using a cut off of 2.5 Å,
gives rise to 10 and 3 clusters for the binary and ternary complexes
respectively, confirming that the protein in presence of IQN2
samples a reduced conformational space. The first three clusters of
the binary complex account for 85% of the total structures, while
in the ternary complex 99% of the conformations are represented
by the first cluster, highlighting the extreme rigidity of the protein
stabilized by the drug. Clustering of the linker domain using a cut
off of 1.6 Å and fitting the linker on itself highlights the different
conformational space sampled by this domain in the two systems,
giving rise to 33 clusters in the binary complex and 13 in the
ternary one (Figure 2A1 and 2B1). In this case 90% of the total
conformations reside in the first 5 and 2 clusters for the binary and
ternary simulations, respectively. Clustering of the relative
orientations of the linker respect to the core domain, using the
same cut off, gives rise to 15 clusters in the binary complex and 11
in the ternary one (Fig. 2A2 and 2B2). As a result f this clustering
90% of the total conformations belong to the first 3 clusters for the
binary complex and to the first cluster for the ternary one.
Principal component analysis carried out on the Ca atoms
shows that 60% of total motion is represented by the first 4
eigenvectors in the binary complex indicating (Supporting Figure
S2), indicating that 60% of the total motion is spread toward four
different directions, while in the presence of IQN2 the same
percentage of motion is described by the first eigenvector,
confirming that the motion of the protein is core confined in the
presence of the drug (Supporting Figure S2). This can be well
appreciated by the plot of the projection of the Ca atoms
trajectories on the plane formed by the first and second
eigenvectors (Supporting Figure S3A) and by the first and third
PLOS ONE | www.plosone.org

Figure 2. Cluster analysis. Overlap of the linker representative
clusters in the binary (A1 and A2) and ternary (B1 and B2) complexes.
The linker is represented as a coil and the color scale is red-white-blue
from the most to the less populated cluster. On the top (A1 and B1) the
representative structures obtained upon fitting on the linker itself are
reported, while on the bottom (A2 an B2) the representative structures
obtained upon fitting on the core and C-terminal domains of the
protein.
doi:10.1371/journal.pone.0051354.g002

eigenvectors (Supporting Figure S3B), both showing that the
protein in the ternary complex samples a low conformational
space being the motion confined in a single basin, while a much
larger space is sampled by the protein in the binary complex
(Supporting Figure S3). In line, the amplitude of motion along the
first eigenvector is 193 Å and 117 Å for the binary and ternary
complex, respectively (Supporting Figure S3).
A reduced linker flexibility in the ternary complex is also
confirmed by the plot of the per-residue RMSF calculation
(Figure 3) of the binary and ternary complex. The plot shows that
also residues 587–630, corresponding to helices 16 and 17 in the
C-terminal portion of subdomain III, and residues 717–765,
corresponding to helices 20–22 in the C-terminal domain, are less
flexible in the ternary complex. Another large difference is
detected at the level of Glu497, a residue belonging to the Lip2
that, from the X-ray diffraction study of the binary complex, is
known to clamp the DNA substrate interacting via a salt bridge
with Lys369 belonging to Lip1 [3,4]. Analysis of the MD
trajectories indicates that this interaction is present for 100% of
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interfaces helices 17 and 21 has been considered for the calculation
(Supporting Figure S4). In all the cases the distance is larger and
more fluctuating in the binary complex than in the ternary one,
indicating that the presence of the drug makes the helix bundle
more compact (Figure 5). The bundle is proximal to the active site
and thus to the drug binding site (Supporting Figure S4), so it is
directly influenced by the presence of the drug itself. To detect at
molecular level the effect of the drug on the mobility of the linker
and of the helices bundle, we have investigated the interactions
occurring between the protein-DNA and protein-DNA-drug
complexes, focusing our attention on the Asn722 and Arg364,
involved in the drug binding [13,22].
In the crystal structure of the binary complex Asn722, located
on helix 20, binds Thr718 via a backbone-backbone interaction
while Arg364, located on Lip1, establishes a hydrogen bond with
Gua +1 of the scissed strand [13]. In the simulation, Asn722
maintains the backbone-backbone interaction with Thr718 and
establishes a direct contact with Thy -1 of the scissile strand over
all the simulation time, whilst Arg364 establishes two water
mediated contacts with the guanines in position +1 e +2 of the
scissile strand, over all the simulation time (Table 1, Figure 6A and
Supporting Figure S5A).
In the crystal structure of the ternary complex in presence of the
AI-III-52 compound, having the same scaffold for the here
presented IQN2, the drug is stabilized by a direct interaction of
the methoxy substituent in position 2 with the lateral chain of
Asn722 and by a direct interaction between the nitrogen atom in
position 6 and the lateral chain of Arg364 [21,22]. In comparison
to the binary complex crystal structure, Arg364 loses the
interaction with Gua +1 and establishes a new interaction with
Asp533, whilst Asn722 maintains the backbone-backbone interaction with Thr718 and establishes with its lateral chain, that

total simulation time in the ternary complex, but for only 36% of
simulation time in the binary one, where several conformations are
reached. A plot of the distance between the carboxylic group of
Glu497 and the amino group of Lys369 as a function of time
indicates that this distance is highly fluctuating, since the
interaction is partially lost after 18 ns and then occurs again at
around 20 ns for 2 ns, and then is lost again, the two groups
reaching a distance up to 20 Å (Figure 4A). Two representative
conformations extracted from the binary and ternary complex are
shown in Figure 4B and C to better appreciate the difference
between the two systems, where the two residues are at a distance
of 20 Å and 2.4 Å, respectively. The loss of the inter-lips
interaction explains the high mobility of residue 497 in the
absence of IQN2 and for the first time provides a picture of the
events that must continuously occur during the cleavage and
religation steps carried out by the enzyme [5]. It is interesting that
in the same temporal window such a process never occurs in the
ternary complex, where a constant average distance of 5 Å is
observed during all the trajectory (Figure 4C), indicating that the
presence of the drug increases the stability of the clamp around the
DNA.

IQN2 Environment and Compactness of the Helix Bundle
Proximal to the Active Site
As shown by the plot of the RMSF, the presence of IQN2 affects
not only the mobility of the linker domain, but also of helices 16–
17 in core subdomain III and 20–22 in the C-terminal domain
(Supporting Figure S4). The interaction between these helices has
been analyzed in detail by plotting the distance between the
centres of mass of the following couples of helices: 17–21, 19–20
and 19–21 (Figure 5). In the case of helix 19 only the C-terminal
region, corresponding to residues 699 to 726, that directly

Figure 3. Root Mean Square Fluctuation. Per-residue root mean square fluctuation (RMSF) of binary (full black line) and ternary (red dot-dashed
line) complex trajectories calculated along the entire sampling interval (75 ns).
doi:10.1371/journal.pone.0051354.g003
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Figure 4. Interaction between the lips. (A) atomic distance between the Nf atom of Lys369 and the center of mass of OE1 and OE2 of
Glu497 as a function of time in the binary (black line) and ternary (red line) complexes. Representative snapshots extracted from the
simulations of the binary (B) and ternary (C) complexes showing the relative positions of Lips 1 and 2 and of residues Lys369 and Glu497.
doi:10.1371/journal.pone.0051354.g004

of the Gua +1 base of the scissile strand (Table 1 and Figure 6B).
Moreover, the Asn722-Thr718 backbone-backbone and lateral
chain-backbone hydrogen bonds are maintained over all the
simulation time (Supporting Figure S5), avoiding the formation of
the Asn722-Gua +2 and Thr718-Thy -1 hydrogen bonds observed
for more than 95% of the binary complex simulation time
(Table 1).
The stable interactions between Asn722 and Thr718, both
located on helix 20, coupled with the constant hydrogen bond

now has new orientation induced by the drug, an additional
interaction with the backbone of Thr718.
In the simulation, the interaction of the IQN2 drug with Asn722
is maintained over all the trajectory (Table 1 and Figure 6B). In
the case of Arg364, its lateral chain binds the drug via a water
mediated contact at the level of the of the oxygen substituent in
position 5, being the N6 atom of IQN2 not available due to the
presence of the methyl substituent (Table 1 and Figure 6B). The
drug is further stabilized by a direct contact with DNA, at the level

PLOS ONE | www.plosone.org
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Figure 5. Analysis of the helix bundle. Atomic distance between the centre of masses of helices 17–19 (A), 19–20 (B) and 19–21 (C). The black
and red lines represent the distances calculated in the binary and ternary complexes, respectively.
doi:10.1371/journal.pone.0051354.g005

simulation time (Table 1 and Figure 6B). This interaction forces
Asn722 to interact with Thr718 more tightly than in the binary
complex, blocking the fluctuation of the helix and of the entire
cluster, including the C-terminal part of helix 19, one of the two
helices composing the linker domain. This domain is indeed less
flexible in the ternary complex than in the binary one as evidenced
by the RMSF analysis (Figure 3) and, more importantly, it samples
a smaller conformational space as shown by PCA and cluster
analyses (Figure 2, and Supporting Figures S2 and S3). In
a previous simulation carried out in presence of topotecan (TPT),
the linker was also found to sample a smaller conformational
space, but in this case this was due to an increased rigidity of the
loop connecting the linker with subdomain III (14) and not to an
increased compactness of the helices 16–21 bundle. It is interesting
to notice that the same effect, i.e. a reduction of the conformational space sampled by the linker, is achieved by the two drugs
through two different mechanisms.
A direct correlation between linker mobility and TPT reactivity
has been shown upon a comparison of the electron density maps of
the enzyme crystals in the presence or absence of TPT [14], where
the linker density is observed only in presence of the drug,
confirming the fundamental role of this domain required for an
efficient drug inhibition as experimentally demonstrated by
Champoux and co-workers [39,40]. The increased mobility of
the linker has been shown to be the most likely explanation for the

between by Asn722 and IQN2, provides an explanation for the
reduced mobility of helix 20, of the bundle formed by helix 20
itself together with helices 16–17–19–21 and of the linker domain,
observed in the ternary complex (Figure 3).
Another interesting difference between the binary and ternary
complexes concerns the different orientation of the active site
residue Lys532, that acts as a general acid in the religation step,
receiving the proton from the +1 base [36–38]. In the binary
complex Lys532 interacts with Gua +1 for the 95% of the total
simulation time, while this interaction is never observed in the
ternary complex (Table 1), where the Lys532-Gua +1 distance is
more variable and reaches a final value of 9.8 Å, instead of the
3.2 Å constant value observed in the binary complex (Supporting
Figure S6).

Discussion
The effect of IQN2 on the structure and dynamics of the
hTopIB-DNA complex has been probed by molecular dynamics
simulations of the binary and ternary complexes. The results show
that the presence of IQN2 affects the flexibility of the protein,
reducing the conformational space visited by the linker domain,
helices 16–17 in subdomain III and helices 20–22 in the Cterminal domain (Figure 3). This is due to the direct interaction
between IQN2 and Asn722, located on helix 20, present for all the
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Table 1. Hydrogen bonds between hTopIB and DNA.

Donor

Acceptor

Hydrogen Bond Lifetime (%)

ARG364

G +2 s

98.5

wm

ARG364

G +1 s

90.2

wm

ASN722

T -1 s

99.6

wm

G +2 s

ARG364

91.8

wm

Binary

LYS425

C +1 u

92.6

THR718

G +2 s

95.8

LYS532

G +1 s

95.96

SER534

G -3 u

90.7

W

ASN574

T -6 u

92.9

wm

LYS587

C -5 u

99.9

LYS587

T -2 s

96.6

LYP587

T -1 s

94.4

ARG364

IQN

96.7

wm

Ternary

ASN722

IQN

96.3

G +1 s

IQN

51.3

wm

Hydrogen bonds between hTopIB and DNA present in either the binary or
ternary complex trajectory for at least 85% of sampling (with the exception of
the last bond between the drug and the guanine residue in position +1 on the
cleaved strand).
Wm
) A water molecule capable of hydrogen bonding is present at least in 50%
of the analyzed frames.
W
) The indicated value refers to a water mediated hydrogen bond since a direct
bond is present in less than 85 of analyzed frames.
doi:10.1371/journal.pone.0051354.t001

Figure 6. Active site and IQN interactions. Snapshots of the
cleavage site in the binary and ternary complexes. Amino acids are
represented in green while nucleotides are either yellow or represent in
ball and stick with different colors for various atom types. Black dotted
lines indicate hydrogen bonds between the drug, DNA or hTopIB
residues described in the text or in Tables. (A) snapshot of the cleavage
site in the binary complex. (B) snapshot of the drug binding pocket in
the ternary complex.
doi:10.1371/journal.pone.0051354.g006

CPT resistance displayed by the mutant in which alanine at 653 is
substituted with a proline [41], whilst a reduced linker mobility has
been correlated to the enzyme drug hypersensitivity, observed
upon multiple linker mutations [42,43]. Recently, an increased
linker structural flexibility has been suggested to explain the CPT
resistance of the linker-located Glu710Gly mutation [44]. Here we
show a reduction of the conformational space sampled by the
linker, achieved through a direct interaction of IQN2 with helix
20, and the following tight packing of helices 16–21, including the
C-terminal region of helix 19, one of the two helices forming the
linker domain. The reduced protein mobility that induces
a stronger inter-lips interaction (Figure 4). Actually, in this work
we show for the first time that the Lys369-Glu497 salt bridge
between the two lips is lost for a large time during the trajectory in
the binary complex but that this never occurs in the hTopIBDNA-IQN2 ternary complex (Figure 4), indicating the efficient
conformational stabilization of the cleavage complex induced by
IQN2.
An interesting observation concerns the fact that despite IQN2
and TPT display a different network of interactions with the
protein, as highlighted by the superposition of the two drugs in the
ternary complexes reported in Figure 7, they induce two main
identical effects, even if achieved by distinct molecular mechanisms. The first one is the already described reduction of the
conformational space of the linker, due to the rigidity of residues
633–644 in the case of TPT and of helices 16–21 in the case of
IQN, the second one is the lengthening of the Lys532-Gua +1
distance, due to the direct interaction of residue Lys532 with TPT
in one case and to the direct interaction of Gua +1 with IQN2 in
the other one (Supporting Figure S6). The first event induces
PLOS ONE | www.plosone.org

a reduced protein mobility and the second one impedes the
religation process.
A final comment concerns the presence on IQN2 of the
methoxy groups in position 2 and 3 that contribute to the
religation inhibition through the reduction of protein mobility due
to hydrogen bonding interaction with Asn722, (figure 6) and of the
acceptor groups in position 5 or 11 that play a key role in the
interaction with Arg364 (figure 6). This study indicates that these

Figure 7. IQN and TPT binding pocket. Superposition of TPT and
IQN into the DNA in the ternary complex. Thr718, Asn722 and Arg364
are shown.
doi:10.1371/journal.pone.0051354.g007
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features are important requisites to conformationally stabilize the
cleavage complex and to reduce linker mobility, and their presence
must be considered in the design of efficient hTopIB drugs.

Figure S4 Helix bundle. Representation of the helix bundle

Supporting Information

Figure S5 Time evolution of the distance between
Asn722 and Thr718. Atomic distance as a function of time
between the N atom of Asn722 and the O atom of Thr718 (A) and
between the ND atom of Asn722 and the O atom of Thr718 (B).
In both graphs the black and red lines represent the binary and
ternary complex, respectively.
(TIF)

16–21. The protein and DNA are represented in ribbon, with the
helices of the bundle reported in red.
(TIF)

Figure S1 Root Mean Square Deviation. RMSD of Ca
atoms calculated as a function of time for the full protein in the
binary complex (black dashed line) and for the protein without the
linker domain (black full line) and for the full protein in the ternary
complex (red dashed line) and for the protein without the linker
domain (red full line).
(TIF)

Figure S6 Time evolution of the distance between
Lys532 and Gua +1. Atomic distance as a function of time
between the Nf of Lys532 and the O59 atom of Gua +1. The
trajectories of the binary and ternary complexes are reported in
black and red, respectively.
(TIF)

Figure S2 Weight of eigenvectors. Cumulative percentage of
motion as a function of eigenvectors for the 565 Ca atoms
(residues 201–765) of the protein in the binary and ternary
complexes (black and red lines, respectively).
(TIF)

Author Contributions

Figure S3 Amplitude of the motion along the first two
eigenvectors. Projection of the motion along the planes formed
by eigenvectors 1–2 (A) and 1–3 (B). The binary and ternary
complexes are reported in black and red, respectively.
(TIF)
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